Sven Perner

32.2k total citations · 1 hit paper
269 papers, 12.9k citations indexed

About

Sven Perner is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Sven Perner has authored 269 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Pulmonary and Respiratory Medicine, 115 papers in Molecular Biology and 83 papers in Oncology. Recurrent topics in Sven Perner's work include Prostate Cancer Treatment and Research (97 papers), Prostate Cancer Diagnosis and Treatment (40 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Sven Perner is often cited by papers focused on Prostate Cancer Treatment and Research (97 papers), Prostate Cancer Diagnosis and Treatment (40 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Sven Perner collaborates with scholars based in Germany, United States and Switzerland. Sven Perner's co-authors include Mark A. Rubin, Rainer Kuefer, Arul M. Chinnaiyan, Rajal B. Shah, Scott A. Tomlins, Joëlle Tchinda, Rohit Mehra, Kenneth J. Pienta, Charles Lee and Saravana M. Dhanasekaran and has published in prestigious journals such as Science, Nature Communications and Nature Genetics.

In The Last Decade

Sven Perner

256 papers receiving 12.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

2005 2.8k citations Scott A. Tomlins, Daniel R. Rhodes et al. Science profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Sven Perner	6.9k	6.5k	3.8k	3.1k	1.0k	269	12.9k
Rohit Mehra	8.2k 1.2×	7.2k 1.1×	4.1k 1.1×	2.7k 0.9×	920 0.9×	214	13.8k
Rajal B. Shah	8.9k 1.3×	7.6k 1.2×	3.9k 1.0×	2.5k 0.8×	1.1k 1.1×	153	14.9k
Felix Y. Feng	7.3k 1.1×	7.4k 1.1×	6.2k 1.7×	3.3k 1.1×	1.2k 1.1×	444	16.2k
Jiaoti Huang	8.2k 1.2×	7.3k 1.1×	3.8k 1.0×	4.3k 1.4×	1.7k 1.7×	308	16.4k
William Kevin Kelly	6.3k 0.9×	5.0k 0.8×	2.0k 0.5×	3.9k 1.2×	1.9k 1.8×	244	11.9k
Peter Schraml	3.3k 0.5×	7.4k 1.1×	3.5k 0.9×	4.5k 1.4×	933 0.9×	158	12.1k
Shinichi Toyooka	8.8k 1.3×	7.7k 1.2×	3.3k 0.9×	6.5k 2.1×	833 0.8×	519	16.1k
David M. Jablons	5.2k 0.7×	6.9k 1.1×	2.0k 0.5×	4.8k 1.5×	595 0.6×	273	14.2k
Ronald Simon	3.9k 0.6×	6.9k 1.1×	3.4k 0.9×	5.2k 1.7×	1.2k 1.2×	357	13.5k
W. Kimryn Rathmell	4.6k 0.7×	6.6k 1.0×	3.9k 1.0×	2.4k 0.8×	559 0.5×	232	10.3k

Countries citing papers authored by Sven Perner

Since Specialization

Citations

This map shows the geographic impact of Sven Perner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Perner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Perner more than expected).

Fields of papers citing papers by Sven Perner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Perner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Perner. The network helps show where Sven Perner may publish in the future.

Co-authorship network of co-authors of Sven Perner

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Perner. A scholar is included among the top collaborators of Sven Perner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Perner. Sven Perner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Köster, Frank, Karen Bräutigam, Achim Rody, et al.. (2025). Prognostic and clinical heterogeneity of PD1 and PD-L1- immunohistochemical scores in endometrial cancers. Archives of Gynecology and Obstetrics. 311(5). 1395–1405.

Nair, Vidhya, Iman M. Talaat, Hauke Busch, et al.. (2023). Immunohistochemical Expression Analysis of Caldesmon Isoforms in Colorectal Carcinoma Reveals Interesting Correlations with Tumor Characteristics. International Journal of Molecular Sciences. 24(3). 2275–2275. 5 indexed citations

Ribbat‐Idel, Julika, et al.. (2023). Disseminated ectopic pregnancy after salpingotomy in a 30‐year‐old patient. SHILAP Revista de lepidopterología. 11(4). e7160–e7160. 1 indexed citations

Keller, Laura, Gunhild von Amsberg, Natalia Bednarz‐Knoll, et al.. (2022). Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer. Clinical Chemistry. 68(7). 973–983. 3 indexed citations

Idel, Christian, Julika Ribbat‐Idel, Dirk Rades, et al.. (2020). CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC. International Journal of Molecular Sciences. 21(15). 5508–5508. 7 indexed citations

Idel, Christian, Julika Ribbat‐Idel, Rosemarie Krupar, et al.. (2020). EVI1 as a Marker for Lymph Node Metastasis in HNSCC. International Journal of Molecular Sciences. 21(3). 854–854. 19 indexed citations

Ribbat‐Idel, Julika, Karl‐Ludwig Bruchhage, Dirk Rades, et al.. (2020). NR2F6 as a Prognostic Biomarker in HNSCC. International Journal of Molecular Sciences. 21(15). 5527–5527. 15 indexed citations

Marwitz, Sebastian, Lena Heinbockel, Christian Kügler, et al.. (2018). Fountain of youth for squamous cell carcinomas? On the epigenetic age of non‐small cell lung cancer and corresponding tumor‐free lung tissues. International Journal of Cancer. 143(12). 3061–3070. 5 indexed citations

Schmitt, Anna, Gero Knittel, Tsun-Po Yang, et al.. (2017). ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma. Cancer Research. 77(11). 3040–3056. 82 indexed citations

10.

Marwitz, Sebastian, et al.. (2017). Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression. Clinical Epigenetics. 9(1). 51–51. 54 indexed citations

11.

Marek, Lindsay A., Trista K. Hinz, Anne von Mäßenhausen, et al.. (2014). Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma. Molecular Cancer Research. 12(10). 1460–1469. 33 indexed citations

12.

Wynes, Murry W., Trista K. Hinz, Dexiang Gao, et al.. (2014). FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies. Clinical Cancer Research. 20(12). 3299–3309. 125 indexed citations

13.

Schröck, Andreas, Friederike Göke, Petra M. Bareiss, et al.. (2014). Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma. Carcinogenesis. 35(7). 1636–1642. 64 indexed citations

14.

Bareiss, Petra M., Anna Paczulla, Hui Wang, et al.. (2013). SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma. Cancer Research. 73(17). 5544–5555. 126 indexed citations

15.

Scheble, Veit, Petra M. Bareiss, Anna Fischer, et al.. (2013). SOX2 Expression and Prognostic Significance in Ovarian Carcinoma. International Journal of Gynecological Pathology. 32(4). 358–367. 32 indexed citations

16.

Jané‐Valbuena, Judit, Hans R. Widlund, Sven Perner, et al.. (2010). An Oncogenic Role for ETV1 in Melanoma. Cancer Research. 70(5). 2075–2084. 81 indexed citations

17.

Mosquera, Juan Miguel, Rohit Mehra, Meredith M. Regan, et al.. (2009). Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States. Clinical Cancer Research. 15(14). 4706–4711. 164 indexed citations

18.

Hofer, Matthias D., Rainer Kuefer, Christiane Maier, et al.. (2009). Genome-Wide Linkage Analysis of TMPRSS2-ERG Fusion in Familial Prostate Cancer. Cancer Research. 69(2). 640–646. 25 indexed citations

19.

Perner, Sven, Francesca Demichelis, Rameen Beroukhim, et al.. (2006). TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer. Cancer Research. 66(17). 8337–8341. 388 indexed citations

20.

Tomlins, Scott A., Daniel R. Rhodes, Sven Perner, et al.. (2005). Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer. Science. 310(5748). 644–648. 2820 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact